Assessing Interactions between the Association of Common Genetic Variant at 1p11 (rs11249433) and Hormone Receptor Status with Breast Cancer Risk

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Chen, Qian ^a   Shi, Rongliang ^a   Liu, Weiyan ^a   Jiang, Daowen ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AFRICA; ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CHROMOSOME 1P; CHROMOSOME 1P11; DISEASE ASSOCIATION; ETHNICITY; GENETIC VARIABILITY; HUMAN; RANDOM EFFECTS MODEL; RECESSIVE GENE; STATISTICAL MODEL; BREAST TUMOR; CHROMOSOME 1; CONFIDENCE INTERVAL; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PUBLISHING; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS;

EID: 84881600353     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072487     Document Type: Article

References (44)

1. Shulman LN, Willett W, Sievers A, Knaul FM, (2010) Breast cancer in developing countries: opportunities for improved survival. J Oncol 2010: 595167.
2. Porter P, (2008) "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med 358: 213-216.
3. McPherson K, Steel CM, Dixon JM, (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321: 624-628.
4. Nathanson KL, Wooster R, Weber BL, (2001) Breast cancer genetics: what we know and what we need. Nat Med 7: 552-556.
5. Balmain A, Gray J, Ponder B, (2003) The genetics and genomics of cancer. Nat Genet 33(suppl): 238-244.
6. Benson JR, Jatoi I, (2012) The global breast cancer burden. Future Oncol 8: 697-702.
7. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85.
8. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
9. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, et al. (2009) Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 41: 585-590.
10. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, et al. (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42: 504-507.
11. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362-9367.
12. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, et al. (2009) A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 41: 579-584.
13. Palomaki GE, Melillo S, Bradley LA, (2010) Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA 303: 648-656.
14. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
15. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
16. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
17. Tobias A, (1998) Assessing the infl{ligature}uence of a single study in the meta-analysis estimate. Stata Tech Bull 8: 15-17.
18. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
19. Taylor SJ, Tweedie RI, (1998) Practical estimates of the effect of publication bias in meta-analysis. Australas Epidemiol 5: 14-17.
20. He C, Chasman DI, Dreyfus J, Hwang SJ, Ruiter R, et al. (2012) Reproductive aging-associated common genetic variants and the risk of breast cancer. Breast Cancer Res 14: R54.
21. Sueta A, Ito H, Kawase T, Hirose K, Hosono S, et al. (2012) A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Res Treat 132: 711-721.
22. Kim HC, Lee JY, Sung H, Choi JY, Park SK, et al. (2012) A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res 14: R56.
23. Huo D, Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, et al. (2012) Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis 33: 835-840.
24. Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, et al. (2011) Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 20: 3304-3321.
25. Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, et al. (2011) Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 20: 4693-4706.
26. Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, et al. (2011) Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst 103: 1252-1263.
27. Jiang Y, Shen H, Liu X, Dai J, Jin G, et al. (2011) Genetic variants at 1p11.2 and breast cancer risk: a two-stage study in Chinese women. PLoS One 6: e21563.
28. Chen F, Chen GK, Millikan RC, John EM, Ambrosone CB, et al. (2011) Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans. Hum Mol Genet 20: 4491-4503.
29. Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, et al. (2011) Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 71: 6240-6429.
30. Hutter CM, Young AM, Ochs-Balcom HM, Carty CL, Wang T, et al. (2011) Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study. Cancer Epidemiol Biomarkers Prev 20: 1950-1959.
31. Li J, Humphreys K, Heikkinen T, Aittomäki K, Blomqvist C, et al. (2011) A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res Treat 126: 717-727.
32. Bhatti P, Doody MM, Rajaraman P, Alexander BH, Yeager M, et al. (2010) Novel breast cancer risk alleles and interaction with ionizing radiation among U.S. Radiologic Technologists. Radiat Res 173: 214-224.
33. Long J, Shu XO, Cai Q, Gao YT, Zheng Y, et al. (2010) Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev 19: 2357-2365.
34. Risch N, Merikangas K, (1996) The future of genetic studies of complex human diseases. Science 273: 1516-1517.
35. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN, (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177-182.
36. Munafo MR, Flint J, (2004) Meta-analysis of genetic association studies. Trends Genet 20: 439-444.
37. Hirschhorn JN, Lohmueller K, Byrne E, (2002) A comprehensive review of genetic association studies. Genet Med 4: 45-61.
38. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, et al. (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10: 5367-5374.
39. Yang XR, Pfeiffer RM, Garcia-Closas M, Rimm DL, Lissowska J, et al. (2007) Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. Cancer Res 67: 10608-10617.
40. Allred DC, Brown P, Medina D, (2004) The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res 6: 240-245.
41. Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, et al. (2010) NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations. Mol Cancer 9: 113.
42. Alimirah F, Panchanathan R, Davis FJ, Chen J, Choubey D, (2007) Restoration of p53 expression in human cancer cell lines upregulates the expression of Notch1: implications for cancer cell fate determination after genotoxic stress. Neoplasia 9: 427-434.
43. Yugawa T, Handa K, Narisawa-Saito M, Ohno S, Fujita M, et al. (2007) Regulation of Notch1 gene expression by p53 in epithelial cells. Mol Cell Biol 27: 3732-3742.
44. Bouras T, Pal B, Vaillant F, Harburg G, Asselin-Labat ML, et al. (2008) Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 3: 429-441.